According to new data released on Wednesday, drug overdose fatalities in the US saw a significant decrease in 2024, reaching their lowest levels in five years, which brings a glimmer of hope in the ongoing struggle against the opioid crisis.
Approximately 80,391 individuals lost their lives to drug overdoses last year, marking a 27% drop from the 110,035 deaths reported since 2019.
Fentanyl-related fatalities also declined to 48,422 in 2024, down from about 76,000 in 2023, with only South Dakota and Nevada seeing an increase.
This reduction occurred during the administration of former President Joe Biden, who focused on expanding access to addiction treatment and emphasized the opioid reversal medication naloxone within national drug policy.
Nevertheless, the Trump administration, now in power again, quickly took credit for the positive trends.
The Centers for Disease Control noted in a statement, “Since President Trump declared the opioid crisis a public health emergency in 2017, Congressional backing has enabled the CDC to enhance its vital data systems and bolster its overdose prevention efforts nationwide.”
Despite these improvements, the statement emphasized that overdose remains the leading cause of death for Americans aged 18-44, reflecting the need for continued efforts to sustain this progress.
The epidemic of opioid misuse traces back to the 1990s when pharmaceutical companies aggressively marketed prescription pain medications such as OxyContin.
The current surge in overdoses is mainly driven by illegally produced fentanyl, which is primarily manufactured in China and trafficked to the US via Mexico. This substance is frequently combined with stimulants like methamphetamine and cocaine.
Overdose deaths escalated during the COVID-19 pandemic, exacerbated by increasing disruptions and mental health challenges.
In total, more than 1 million Americans have succumbed to drug overdoses over the past two decades.
